{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:25:13Z","timestamp":1793910313473,"version":"4.8.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":106,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.prdoa.2025.100331","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T02:49:28Z","timestamp":1744944568000},"page":"100331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Longitudinal Assessment of Parkinson\u2019s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN"],"prefix":"10.1016","volume":"12","author":[{"given":"Amir Hossein","family":"Najmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Ariaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Khezri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6188-4650","authenticated-orcid":false,"given":"Masoud","family":"Noroozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika Arab","family":"Bafrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avesta","family":"Gheysari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Sabetghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5775-2906","authenticated-orcid":false,"given":"Mehdi","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0351-7876","authenticated-orcid":false,"given":"Mohammad","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Mayeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.prdoa.2025.100331_b0005","doi-asserted-by":"crossref","first-page":"e464","DOI":"10.1016\/S2666-7568(24)00094-1","article-title":"Temporal trends in the prevalence of Parkinson's disease from 1980 to 2023: a systematic review and meta-analysis","volume":"5","author":"Zhu","year":"2024","journal-title":"Lancet Healthy Longevity"},{"key":"10.1016\/j.prdoa.2025.100331_b0010","doi-asserted-by":"crossref","unstructured":"H. Mohammadi, A. Ariaei, Z. Ghobadi, E.A.C. Gorgich, A. Rustamzadeh, Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer\u2019s disease? An umbrella review, IBRO Neurosci. Rep. (2024).","DOI":"10.1016\/j.ibneur.2024.02.007"},{"key":"10.1016\/j.prdoa.2025.100331_b0015","article-title":"Premotor, nonmotor and motor symptoms of Parkinson's disease: a new clinical state of the art","volume":"84","author":"Silva","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"9996","key":"10.1016\/j.prdoa.2025.100331_b0020","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0025","article-title":"Staging Parkinson\u2019s disease combining motor and nonmotor symptoms correlates with disability and quality of life","volume":"2021","author":"Santos Garc\u00eda","year":"2021","journal-title":"Parkinson\u2019s Dis."},{"issue":"10","key":"10.1016\/j.prdoa.2025.100331_b0030","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/mds.27790","article-title":"Measuring Parkinson's disease over time: the real\u2010world within\u2010subject reliability of the MDS\u2010UPDRS","volume":"34","author":"Evers","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100331_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100331_b0040","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1007\/s00415-023-11563-y","article-title":"Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study","volume":"270","author":"Tsang","year":"2023","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41531-022-00404-w","article-title":"Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort","volume":"8","author":"Simuni","year":"2022","journal-title":"npj Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp-2017-316213","article-title":"Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson\u2019s disease: the PPMI cohort","volume":"89","author":"Simuni","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.prdoa.2025.100331_b0055","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale","volume":"28","author":"Stebbins","year":"2013","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100331_b0060","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mds.22875","article-title":"Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times","volume":"25","author":"Zhao","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0065","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000001885","article-title":"Semiquantitative analysis of dopamine transporter scans in patients with Parkinson disease","volume":"43","author":"Tinaz","year":"2018","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-018-0069-x","article-title":"Risk factors of levodopa-induced dyskinesia in Parkinson\u2019s disease: results from the PPMI cohort","volume":"4","author":"Eusebi","year":"2018","journal-title":"npj Parkinson's Dis."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100331_b0075","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jon.12530","article-title":"I\u2010123 DaTscan SPECT brain imaging in parkinsonian syndromes: utility of the putamen\u2010to\u2010caudate ratio","volume":"28","author":"Matesan","year":"2018","journal-title":"J. Neuroimaging"},{"issue":"18","key":"10.1016\/j.prdoa.2025.100331_b0080","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1212\/WNL.0000000000000385","article-title":"Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease","volume":"82","author":"Hong","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100331_b0085","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","article-title":"Disease progression in Parkinson subtypes: the PPMI dataset","volume":"39","author":"Aleksovski","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.prdoa.2025.100331_b0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fneur.2019.00471","article-title":"Alteration of tremor dominant and postural instability gait difficulty subtypes during the progression of Parkinson's disease: analysis of the PPMI cohort","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Neurol."},{"issue":"S7","key":"10.1016\/j.prdoa.2025.100331_b0095","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/mds.10579","article-title":"Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?","volume":"18","author":"Pirker","year":"2003","journal-title":"Movement Disord.: Off. J. Movement Disord. Soc."},{"key":"10.1016\/j.prdoa.2025.100331_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-021-02470-8","article-title":"Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson\u2019s disease trial","volume":"21","author":"Hutchison","year":"2021","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100331_b0105","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae345","article-title":"Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [18F] FE-PE2I PET: independent validation with new insights","volume":"6","author":"Honhar","year":"2024","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100331_b0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-023-00974-7","article-title":"[18F] FE-PE2I DAT correlates with Parkinson\u2019s disease duration, stage, and rigidity\/bradykinesia scores: a PET radioligand validation study","volume":"13","author":"Kerstens","year":"2023","journal-title":"EJNMMI Res."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:17:49Z","timestamp":1775819869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112525000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"alternative-id":["S2590112525000350"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100331","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s00702-025-02999-9","asserted-by":"object"}]},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Assessment of Parkinson\u2019s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100331"}}